For outpatient CAP with risk of Pseudomonas infection, which antibiotic is preferred?

For outpatient CAP with risk of Pseudomonas infection, which antibiotic is preferred?

• A. Amoxicillin with azithromycin or doxycycline
• B. Ceftriaxone
• C. Aztreonam
• D. Levofloxacin

Answer: (D)

When managing outpatient CAP with a risk of Pseudomonas infection, the key is to choose an oral antibiotic with antipseudomonal activity that can be given by mouth. Levofloxacin fits this need well because it’s a respiratory fluoroquinolone with reliable oral bioavailability, good lung penetration, and activity against Pseudomonas aeruginosa as well as the usual CAP pathogens. This allows effective single-agent outpatient therapy for patients who can take oral meds and aren’t severely ill. The other options don’t meet this scenario as effectively: amoxicillin with azithromycin or doxycycline lacks reliable Pseudomonas coverage; ceftriaxone is not reliably antipseudomonal and is typically given IV/IM, not suitable for outpatient use; aztreonam does cover Pseudomonas but is usually administered parenterally and isn’t practical for outpatient therapy.

When managing outpatient CAP with a risk of Pseudomonas infection, the key is to choose an oral antibiotic with antipseudomonal activity that can be given by mouth. Levofloxacin fits this need well because it’s a respiratory fluoroquinolone with reliable oral bioavailability, good lung penetration, and activity against Pseudomonas aeruginosa as well as the usual CAP pathogens. This allows effective single-agent outpatient therapy for patients who can take oral meds and aren’t severely ill.

The other options don’t meet this scenario as effectively: amoxicillin with azithromycin or doxycycline lacks reliable Pseudomonas coverage; ceftriaxone is not reliably antipseudomonal and is typically given IV/IM, not suitable for outpatient use; aztreonam does cover Pseudomonas but is usually administered parenterally and isn’t practical for outpatient therapy.